These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23011873)

  • 1. Mutation in elongation factor G confers resistance to the antibiotic argyrin in the opportunistic pathogen Pseudomonas aeruginosa.
    Bielecki P; Lukat P; Hüsecken K; Dötsch A; Steinmetz H; Hartmann RW; Müller R; Häussler S
    Chembiochem; 2012 Nov; 13(16):2339-45. PubMed ID: 23011873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of Antibacterial Spectrum and Resistance Potential of the Elongation Factor G Inhibitor Argyrin B in Key Gram-Negative Pathogens.
    Jones AK; Woods AL; Takeoka KT; Shen X; Wei JR; Caughlan RE; Dean CR
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of elongation factor G as the conserved cellular target of argyrin B.
    Nyfeler B; Hoepfner D; Palestrant D; Kirby CA; Whitehead L; Yu R; Deng G; Caughlan RE; Woods AL; Jones AK; Barnes SW; Walker JR; Gaulis S; Hauy E; Brachmann SM; Krastel P; Studer C; Riedl R; Estoppey D; Aust T; Movva NR; Wang Z; Salcius M; Michaud GA; McAllister G; Murphy LO; Tallarico JA; Wilson CJ; Dean CR
    PLoS One; 2012; 7(9):e42657. PubMed ID: 22970117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel Evolution of Tobramycin Resistance across Species and Environments.
    Scribner MR; Santos-Lopez A; Marshall CW; Deitrick C; Cooper VS
    mBio; 2020 May; 11(3):. PubMed ID: 32457248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of global patterns and the genetics of fusidic acid resistance.
    Farrell DJ; Castanheira M; Chopra I
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S487-92. PubMed ID: 21546625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global reprogramming of virulence and antibiotic resistance in
    Maunders EA; Triniman RC; Western J; Rahman T; Welch M
    J Biol Chem; 2020 Nov; 295(48):16411-16426. PubMed ID: 32943550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into fusidic acid resistance and sensitivity in EF-G.
    Hansson S; Singh R; Gudkov AT; Liljas A; Logan DT
    J Mol Biol; 2005 May; 348(4):939-49. PubMed ID: 15843024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in Gene
    Bolard A; Plésiat P; Jeannot K
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcus aureus elongation factor G--structure and analysis of a target for fusidic acid.
    Chen Y; Koripella RK; Sanyal S; Selmer M
    FEBS J; 2010 Sep; 277(18):3789-803. PubMed ID: 20718859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of fusidic acid resistance in Staphylococcus aureus.
    Besier S; Ludwig A; Brade V; Wichelhaus TA
    Mol Microbiol; 2003 Jan; 47(2):463-9. PubMed ID: 12519196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC; Wang HB; Sun ZY; Shen ZY
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of fusidic acid-resistant Staphylococcus aureus isolates in the community of Casablanca (Morocco).
    Elazhari M; Abu-Quatouseh LF; Elhabchi D; Zerouali K; Dersi N; Saile R; Timinouni M; Becker K
    Int J Med Microbiol; 2012 Mar; 302(2):96-100. PubMed ID: 22197537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus.
    Besier S; Ludwig A; Brade V; Wichelhaus TA
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1426-31. PubMed ID: 15793122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyper-susceptibility of a fusidic acid-resistant mutant of Salmonella to different classes of antibiotics.
    Macvanin M; Hughes D
    FEMS Microbiol Lett; 2005 Jun; 247(2):215-20. PubMed ID: 15935566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of fluoroquinolone and carbapenem susceptibilities in clinical isolates of levofloxacin-resistant Pseudomonas aeruginosa.
    Muramatsu H; Horii T; Takeshita A; Hashimoto H; Maekawa M
    Chemotherapy; 2005 May; 51(2-3):70-5. PubMed ID: 15870499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dynamic structure of EF-G studied by fusidic acid resistance and internal revertants.
    Johanson U; Aevarsson A; Liljas A; Hughes D
    J Mol Biol; 1996 May; 258(3):420-32. PubMed ID: 8642600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile.
    Norén T; Akerlund T; Wullt M; Burman LG; Unemo M
    Antimicrob Agents Chemother; 2007 May; 51(5):1840-3. PubMed ID: 17307985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in
    Romano KP; Warrier T; Poulsen BE; Nguyen PH; Loftis AR; Saebi A; Pentelute BL; Hung DT
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31235628
    [No Abstract]   [Full Text] [Related]  

  • 19. Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008).
    Castanheira M; Watters AA; Mendes RE; Farrell DJ; Jones RN
    J Antimicrob Chemother; 2010 Jul; 65(7):1353-8. PubMed ID: 20430787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
    Kugelberg E; Löfmark S; Wretlind B; Andersson DI
    J Antimicrob Chemother; 2005 Jan; 55(1):22-30. PubMed ID: 15574475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.